Memantine for Mitigation of Neurocognitive Toxicity Following Radiation to the Brain
Open Access
- 6 January 2021
- journal article
- letter
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 7 (7), 27-28
- https://doi.org/10.1200/GO.20.00551
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Memantine for Prevention of Brain Irradiation–Induced Cognitive Toxicity: A Tale of an Underappreciated and Underused InterventionJCO Global Oncology, 2020
- Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trialNeuro-Oncology, 2013
- Memantine in Moderate to Severe Alzheimer’s Disease: a Meta-Analysis of Randomised Clinical TrialsDementia and Geriatric Cognitive Disorders, 2007